Neueste Veröffentlichungen

• Amendment “New nomenclature for MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)” to the S2k guideline “Non-alcoholic fatty liver disease” (v.2.0/April 2022) of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)
  Article (Journal), Online Resource
• Amendment „Neue Nomenklatur zur MASLD (Metabolic dysfunction associated steatotic liver disease; metabolische Dysfunktion assoziierte steatotische Lebererkrankung)“ zur S2k-Leitlinie „Nicht-alkoholische Fettlebererkrankung“ (v.2.0/April 2022) der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)
  Article (Journal), Online Resource
• Durvalumab plus gemcitabine and cisplatin in patients with advanced biliary tract cancer: an exploratory analysis of real-world data
  Article (Journal), Online Resource
• Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: the prospective phase I PROMETHEUS trial
  Article (Journal), Online Resource
• Etiology-independent activation of the LTβ-LTβR-RELB axis drives aggressiveness and predicts poor prognosis in HCC
  Article (Journal), Online Resource

Alle anzeigen (158)
Alle anzeigen (inkl. Paralleltitel) (167)

Co-Autoren

• Schirmacher, Peter
• Mehrabi, Arianeb
• Breuhahn, Kai
• Weiss, Karl Heinz
• Schemmer, Peter

Alle anzeigen (1040)

Publikationsjahre

Publikationstypen